Skip to content

JUNIPER PHARMACEUTICALS INC

CIK 0000821995

← back to feed
Revenue (TTM)
$57.78M
−9.2% YoY Q2 Aug 2018
Net Income (TTM)
−$2.53M
+182.8% YoY Q2 Aug 2018
EPS Diluted (TTM)
−$0.24
+184.6% YoY Q2 Aug 2018
Gross Margin
42.0%
Q2 Aug 2018
Operating Margin
-4.9%
Q2 Aug 2018
Net Margin
-4.4%
Q2 Aug 2018
Free Cash Flow (TTM)
−$6.58M
Q2 Aug 2018
Cash
$20.83M
Q2 Aug 2018
Total Debt
$3.8M
Q2 Aug 2018
Shares Outstanding
11.32M sh
Q2 Aug 2018

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings